Development of a Care Pathway for Patient's with Suspected PML

Background:  patient with suspected PML following 42 months of treatment with tysabri.

Objectives:  To increase vigilance and identification of suspected PML through a structured nurse led care pathway.

Methods:  identification of key points in the assessment process through critical reflection, development of a care pathway and implementation.

Results:  improved monitoring of patients undergoing tysabri infusions and early intervention in patients identified as potential PML cases

Conclusions:  Through development of a structured nurse led care pathway, increased vigilance and earlier identification of potential patient safety concerns wil be achieved.